Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Johns Hopkins and ImmunoCellular Therapeutics enter licensing agreement for cancer antigen

March 1, 2012

OncoTherapy Science updates on cancer peptide vaccine pipeline

March 1, 2012

Advaxis reports data from first cohort in phase II ADXS-HPV trial

Feb. 28, 2012

Stem CentRx reports new APCDD1-binding antibodies

Feb. 28, 2012

FDA approves protocol amendment to ARISER study

Feb. 27, 2012

Phase I trials assess Listeria-based vaccines in patients with cancer

Feb. 23, 2012

Trials indicate ipilimumab can be administered with cancer vaccines

Feb. 20, 2012

New candidate cancer immunotherapies developed in France

Feb. 14, 2012

Scientists disclose new CD27-targeted candidate immunotherapeutics

Feb. 14, 2012

Phase I trial of Patrys anticancer antibody meets primary endpoint

Feb. 10, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...